Angiotensin II–Triggered p44/42 Mitogen-Activated Protein Kinase Mediates Sympathetic Excitation in Heart Failure Rats
- 1 August 2008
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 52 (2) , 342-350
- https://doi.org/10.1161/hypertensionaha.108.110445
Abstract
Angiotensin II (Ang II), acting via angiotensin type 1 receptors in the brain, activates the sympathetic nervous system in heart failure (HF). We reported recently that Ang II stimulates mitogen-activated protein kinase (MAPK) to upregulate brain angiotensin type 1 receptors in HF rats. In this study we tested the hypothesis that Ang II–activated MAPK signaling pathways contribute to sympathetic excitation in HF. Intracerebroventricular administration of PD98059 and UO126, 2 selective p44/42 MAPK inhibitors, induced significant decreases in mean arterial pressure, heart rate, and renal sympathetic nerve activity in HF rats, but had no effect on these variables in sham-operated rats. Pretreatment with losartan attenuated the effects of PD98059. Intracerebroventricular administration of the p38 MAPK inhibitor SB203580 and the c-Jun N-terminal kinase inhibitor SP600125 had no effect on mean arterial pressure, heart rate, or renal sympathetic nerve activity in HF. The phosphatidylinositol 3-kinase inhibitor LY294002 induced a small decrease in mean arterial pressure and heart rate but no change in renal sympathetic nerve activity. Immunofluorescent staining demonstrated increased p44/42 MAPK activity in neurons of the paraventricular nucleus of the hypothalamus of HF rats, colocalized with Fra-like activity (indicating chronic neuronal excitation). Intracerebroventricular PD98059 and UO126 reduced Fra-like activity in the paraventricular nucleus of the hypothalamus neurons in HF rats. In confirmatory acute studies, intracerebroventricular Ang II increased mean arterial pressure, heart rate, and renal sympathetic nerve activity in baroreceptor-denervated rats and Fra-like immunoreactivity in the paraventricular nucleus of the hypothalamus of neurally intact rats. Central administration of PD98059 markedly reduced these responses. These data demonstrate that intracellular p44/42 MAPK activity contributes to Ang II–induced neuronal excitation in the paraventricular nucleus of the hypothalamus and augmented sympathetic nerve activity in rats with HF.Keywords
This publication has 35 references indexed in Scilit:
- The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failurePublished by Elsevier ,2010
- NADPH Oxidase–Derived Superoxide Anion Mediates Angiotensin II–Induced Pressor Effect via Activation of p38 Mitogen–Activated Protein Kinase in the Rostral Ventrolateral MedullaCirculation Research, 2005
- The Regulation of Sympathetic Nerve Activity by Angiotensin II Involves Reactive Oxygen Species and MAPKCirculation Research, 2005
- The origin of sympathetic outflow in heart failure: the roles of angiotensin II and nitric oxideProgress in Biophysics and Molecular Biology, 2003
- Cytokine Suppression of Dopamine-β-hydroxylase by Extracellular Signal-regulated Kinase-dependent and -independent PathwaysJournal of Biological Chemistry, 2003
- Akt Is a Major Downstream Target of PI3-Kinase Involved in Angiotensin II–Induced ProliferationHypertension, 2003
- Angiotensin II–Induced HypertensionHypertension, 2000
- Angiotensin II-induced cardiac hypertrophy is associated with associated with different mitogen-activated protein kinase activation in normotensive and hypertensive miceJournal Of Hypertension, 2000
- Angiotensin II regulation of neuromodulation: downstream signaling mechanism from activation of mitogen-activated protein kinase.The Journal of cell biology, 1996
- The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failureAmerican Heart Journal, 1989